Published 4 years ago • loading... • Updated 4 years ago
U.S. FDA authorizes Pfizer's COVID booster shot for young children
Summary by Ground News
Pfizer requested this EUA at the end of April. Company data showed that a third vaccine dose raised Omicron-fighting antibodies by 36 times. 4,500 children ages 5 through 11 participated in the Pfizer/BioNTech Covid-19 vaccine trial.